Reprogramming of Hepatic Antigen Presenting Cells Through Epigenetic Mechanisms in Chronic Liver Disease
-
By
-
Enrique Ángel-Gomis
-
Oriol Juanola
-
Esther Caparrós
-
Rubén Francés
-
April 20, 2026
-
Clinical Scorecard: Reprogramming of Hepatic Antigen Presenting Cells Through Epigenetic Mechanisms in Chronic Liver Disease
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Epigenetic regulation of hepatic antigen presenting cells (hAPCs) and their role in maintaining immune tolerance. |
| Target Population | |
| Care Setting | |
Key Highlights
- Research gaps exist regarding the epigenetic regulation of hAPCs and the potential for targeted therapies.
Guideline-Based Recommendations
Diagnosis
Management
- Implement lifestyle modifications and pharmacological interventions (e.g., antivirals, corticosteroids) to manage underlying causes.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Patients with chronic liver disease at various stages.
Focus on managing inflammation and fibrosis through targeted therapies.
Clinical Best Practices
- Integrate multidisciplinary approaches for comprehensive management of CLD.
- Stay updated on emerging research regarding epigenetic interventions.
- Educate patients on lifestyle modifications to support liver health.
References
